Department of Psychiatry, Massachusetts General Hospital, 55 Fruit Street, Yawkey, Suite 10B, Boston, MA, 02114, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
J Clin Psychol Med Settings. 2021 Sep;28(3):603-618. doi: 10.1007/s10880-020-09750-4. Epub 2020 Nov 21.
Adjuvant endocrine therapy (AET) prevents recurrence after early stage, hormone sensitive breast cancer; however, adherence to AET is suboptimal, and efficacious interventions are severely lacking. Barriers to adherence are well established; however, interventions, thus, far have failed to produce meaningful changes in adherence and have generally not followed guiding principles of psychosocial intervention development. The purpose of this paper is to describe the iterative development, using the National Institutes of Health Stage Model for Behavioral Intervention Development, of an evidence-based, patient-centered, telehealth intervention to enhance adherence, improve symptom management, and reduce distress for patients taking AET after breast cancer, with a focus on (1) a small open pilot study which informed modifications and refinement of the intervention based on quantitative and qualitative patient feedback about feasibility and acceptability and (2) the underlying theoretical and empirical rationale for each component of the finalized intervention. Clinical implications and directions for future research are discussed.
辅助内分泌治疗(AET)可预防早期激素敏感型乳腺癌的复发;然而,AET 的依从性并不理想,有效的干预措施严重缺乏。人们已经充分了解了依从性的障碍;然而,迄今为止的干预措施并没有在依从性上产生有意义的变化,并且通常没有遵循心理社会干预发展的指导原则。本文的目的是描述使用美国国立卫生研究院行为干预发展阶段模型对循证、以患者为中心的远程医疗干预措施进行的迭代开发,以增强接受乳腺癌后 AET 治疗的患者的依从性,改善症状管理,并减轻其痛苦,重点是:(1) 一项小型开放试点研究,根据患者对可行性和可接受性的定量和定性反馈,对干预措施进行了修改和完善;(2) 最终干预措施的每个组成部分的基础理论和实证依据。讨论了临床意义和未来研究方向。